We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$54.1B
AUM Growth
+$9.43B
Cap. Flow
+$3.44B
Cap. Flow %
6.35%
Top 10 Hldgs %
12.03%
Holding
3,138
New
250
Increased
1,399
Reduced
1,041
Closed
231

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.5M
2
JCI icon
Johnson Controls International
JCI
+$52.5M
3
EBAY icon
eBay
EBAY
+$49.8M
4
VTR icon
Ventas
VTR
+$46.6M
5
AAPL icon
Apple
AAPL
+$43.5M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Technology 14.94%
3 Healthcare 12.21%
4 Consumer Discretionary 10.01%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHS
2951
DELISTED
Chicos FAS, Inc.
CHS
-80,648
Closed -$453K
RPT
2952
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-35,201
Closed -$421K
AAIC
2953
DELISTED
Arlington Asset Investment Corp.
AAIC
-13,331
Closed -$97K
AVTA
2954
DELISTED
Avantax, Inc. Common Stock
AVTA
-77,572
Closed -$2.07M
NEWR
2955
DELISTED
New Relic, Inc.
NEWR
-6,510
Closed -$527K
TRHC
2956
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-56,563
Closed -$3.6M
TRTN
2957
DELISTED
Triton International Limited
TRTN
-20,609
Closed -$640K
NUVA
2958
DELISTED
NuVasive, Inc.
NUVA
-1,408
Closed -$70K
PDCE
2959
DELISTED
PDC Energy, Inc.
PDCE
-13,878
Closed -$412K
MLVF
2960
DELISTED
Malvern Bancorp, Inc.
MLVF
-2,992
Closed -$59K
MAXR
2961
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-21,461
Closed -$257K
CNCE
2962
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-94,650
Closed -$1.19M
COUP
2963
DELISTED
Coupa Software Incorporated
COUP
-36,364
Closed -$2.29M
SRNE
2964
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-106,819
Closed -$256K
CLVS
2965
DELISTED
Clovis Oncology, Inc.
CLVS
-16,824
Closed -$302K
AERI
2966
DELISTED
Aerie Pharmaceuticals
AERI
-375,935
Closed -$13.5M
ALNA
2967
DELISTED
Allena Pharmaceuticals
ALNA
-17,093
Closed -$93K
EMWP
2968
DELISTED
Eros Media World PLC
EMWP
-4,003
Closed -$663K
EPZM
2969
DELISTED
Epizyme, Inc
EPZM
-7,800
Closed -$48K
CNR
2970
DELISTED
Cornerstone Building Brands, Inc.
CNR
-44,000
Closed -$319K
SREV
2971
DELISTED
ServiceSource International, Inc.
SREV
-1,473,544
Closed -$1.59M
VWTR
2972
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
-20,517
Closed -$188K
PTE
2973
DELISTED
PolarityTE, Inc. Common Stock
PTE
-722
Closed -$244K
VNE
2974
DELISTED
Veoneer, Inc.
VNE
-1,800
Closed -$44K
ARNA
2975
DELISTED
Arena Pharmaceuticals Inc
ARNA
-5,244
Closed -$204K

Similar funds

Russell Investments Group's Q1 2019 Portfolio in Review

As of Q1 2019, Russell Investments Group held 3,138 positions worth $54.1B, up 21% from $44.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Russell Investments Group deployed $3.44B of net new capital in Q1 2019, opening 250 new positions and adding to 1,399 existing holdings. Its largest new stake was American Electric Power Company, Inc. Corporate Unit: 4,210,194 shares worth $2.15M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Celgene Corp, an estimated $75.5M trimmed.

  • Russell Investments Group's largest Q1 2019 buy was American Electric Power Company, Inc. Corporate Unit: 4,210,194 shares worth $2.15M.
  • Russell Investments Group added most to JPMorgan Chase in Q1 2019, an estimated $93.6M increase.
  • Russell Investments Group's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.5M.
  • Russell Investments Group fully exited Aerie Pharmaceuticals in Q1 2019, selling an estimated $13.5M.
  • Russell Investments Group's ten largest holdings make up 12% of its $54.1B portfolio in Q1 2019.
  • Russell Investments Group opened 250 new positions and closed 231 in Q1 2019.
  • Russell Investments Group's portfolio value rose 21% quarter-over-quarter to $54.1B.

Based on Russell Investments Group's 13F filing for Q1 2019, filed 13 May 2019.